Cargando…

Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes

OBJECTIVES: To assess the safety, effectiveness, and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia. METHODS: We conducted a randomized controlled trial and enrolled 500 HIV-negativ...

Descripción completa

Detalles Bibliográficos
Autores principales: Feldblum, Paul J., Zulu, Robert, Linyama, David, Long, Sarah, Nonde, Thikazi Jere, Lai, Jaim Jou, Kashitala, Joshua, Veena, Valentine, Kasonde, Prisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936423/
https://www.ncbi.nlm.nih.gov/pubmed/27331587
http://dx.doi.org/10.1097/QAI.0000000000001015
_version_ 1782441556927578112
author Feldblum, Paul J.
Zulu, Robert
Linyama, David
Long, Sarah
Nonde, Thikazi Jere
Lai, Jaim Jou
Kashitala, Joshua
Veena, Valentine
Kasonde, Prisca
author_facet Feldblum, Paul J.
Zulu, Robert
Linyama, David
Long, Sarah
Nonde, Thikazi Jere
Lai, Jaim Jou
Kashitala, Joshua
Veena, Valentine
Kasonde, Prisca
author_sort Feldblum, Paul J.
collection PubMed
description OBJECTIVES: To assess the safety, effectiveness, and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia. METHODS: We conducted a randomized controlled trial and enrolled 500 HIV-negative men aged 18–49 years at 3 clinics. Participants were randomized to 1 of 2 study arms (Standard Sizing arm vs Modified Sizing arm) in a 1:1 ratio. All 14 adult ShangRing sizes (40–26 mm inner diameter, each varying by 1 mm) were available in the Standard Sizing arm; the Modified Sizing arm used every other size (40, 38, 36, 34, 32, 30, 28 mm inner diameter). Each participant was scheduled for 2 follow-up visits: the removal visit (day 7 after placement) and the healing check visit (day 42 after placement), when they were evaluated for adverse events (AEs), pain, and healing. RESULTS: Four hundred and ninety-six men comprised the analysis population, with 255 in the Standard Sizing arm and 241 in the Modified Sizing arm. Three men experienced a moderate or severe AEs (0.6%), including 2 in the Standard Sizing arm (0.8%) and 1 in the Modified Sizing arm (0.4%). 73.2% of participants were completely healed at the scheduled day 42 healing check visit, with similar percentages across study arms. Virtually all (99.6%) men, regardless of study arm, stated that they were very satisfied or satisfied with the appearance of their circumcised penis, and 98.6% stated that they would recommend ShangRing circumcision to family/friends. CONCLUSIONS: The moderate/severe AE rate was low and similar in the 2 study arms, suggesting that provision of one-half the number of adult device sizes is sufficient for safe service delivery. Effectiveness, time to healing, and acceptability were similar in the study arms. The simplicity of the ShangRing technique, and its relative speed, could facilitate VMMC program goals. In addition, sufficiency of fewer device sizes would simplify logistics and inventory.
format Online
Article
Text
id pubmed-4936423
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-49364232016-07-26 Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes Feldblum, Paul J. Zulu, Robert Linyama, David Long, Sarah Nonde, Thikazi Jere Lai, Jaim Jou Kashitala, Joshua Veena, Valentine Kasonde, Prisca J Acquir Immune Defic Syndr Supplement Article OBJECTIVES: To assess the safety, effectiveness, and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia. METHODS: We conducted a randomized controlled trial and enrolled 500 HIV-negative men aged 18–49 years at 3 clinics. Participants were randomized to 1 of 2 study arms (Standard Sizing arm vs Modified Sizing arm) in a 1:1 ratio. All 14 adult ShangRing sizes (40–26 mm inner diameter, each varying by 1 mm) were available in the Standard Sizing arm; the Modified Sizing arm used every other size (40, 38, 36, 34, 32, 30, 28 mm inner diameter). Each participant was scheduled for 2 follow-up visits: the removal visit (day 7 after placement) and the healing check visit (day 42 after placement), when they were evaluated for adverse events (AEs), pain, and healing. RESULTS: Four hundred and ninety-six men comprised the analysis population, with 255 in the Standard Sizing arm and 241 in the Modified Sizing arm. Three men experienced a moderate or severe AEs (0.6%), including 2 in the Standard Sizing arm (0.8%) and 1 in the Modified Sizing arm (0.4%). 73.2% of participants were completely healed at the scheduled day 42 healing check visit, with similar percentages across study arms. Virtually all (99.6%) men, regardless of study arm, stated that they were very satisfied or satisfied with the appearance of their circumcised penis, and 98.6% stated that they would recommend ShangRing circumcision to family/friends. CONCLUSIONS: The moderate/severe AE rate was low and similar in the 2 study arms, suggesting that provision of one-half the number of adult device sizes is sufficient for safe service delivery. Effectiveness, time to healing, and acceptability were similar in the study arms. The simplicity of the ShangRing technique, and its relative speed, could facilitate VMMC program goals. In addition, sufficiency of fewer device sizes would simplify logistics and inventory. JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-06-01 2016-05-24 /pmc/articles/PMC4936423/ /pubmed/27331587 http://dx.doi.org/10.1097/QAI.0000000000001015 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Supplement Article
Feldblum, Paul J.
Zulu, Robert
Linyama, David
Long, Sarah
Nonde, Thikazi Jere
Lai, Jaim Jou
Kashitala, Joshua
Veena, Valentine
Kasonde, Prisca
Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes
title Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes
title_full Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes
title_fullStr Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes
title_full_unstemmed Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes
title_short Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes
title_sort randomized controlled trial of the shangring for adult medical male circumcision: safety, effectiveness, and acceptability of using 7 versus 14 device sizes
topic Supplement Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936423/
https://www.ncbi.nlm.nih.gov/pubmed/27331587
http://dx.doi.org/10.1097/QAI.0000000000001015
work_keys_str_mv AT feldblumpaulj randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT zulurobert randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT linyamadavid randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT longsarah randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT nondethikazijere randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT laijaimjou randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT kashitalajoshua randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT veenavalentine randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes
AT kasondeprisca randomizedcontrolledtrialoftheshangringforadultmedicalmalecircumcisionsafetyeffectivenessandacceptabilityofusing7versus14devicesizes